Assess the Role of Remimazolam for Procedural Sedation
April 2021
Remimazolam (Byfavo), a new benzodiazepine, will compete with midazolam and propofol for use in procedural sedation.
This type of sedation provides decreased consciousness to perform procedures (colonoscopy, etc) without the need to intubate.
Remimazolam is given as an IV push for sedation induction and maintenance in adults undergoing procedures lasting 30 minutes or less.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote